Concerns rise for COFCO Biotechnology's financial performanc...
Concerns rise for COFCO Biotechnology's financial performance and competitiveness due to decreasing ROCE and sales. Responding to these trends, the stock fell by 11% over five years. Alternatives should be considered unless positive changes occur.
COFCO Biotechnology (SZSE:000930) May Have Issues Allocating Its Capital
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment